NCT04141761View on ClinicalTrials.gov

Probiotics in Newly Diagnosed T1D

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

March 30, 2023

Study Completion Date

June 30, 2027

Conditions
Type 1 DiabetesType1diabetesType 1 Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Visbiome

This group will receive Visbiome probiotic in powder form.

OTHER

Placebo

This group will receive a placebo in powder form.

Trial Locations (1)

53226

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER